Buscar
Congreso SOLACI
Home Tags DAPT

Tag: DAPT

Ticagrelor Monotherapy after 3 Months: Is the Current Strategy Worth Changing?

solaci - 0
La FDA aprueba el ticagrelor en pacientes de alto riesgo como prevención primaria

Abbreviated DAPT in ACS: The End of Clopidogrel Monotherapy?

solaci - 0

Acute Coronary Syndrome: What Is Safer, Antiaggregant Monotherapy or De-Escalation?

solaci - 0
Escándalo con los resultados del EXCEL que hicieron “caer” las últimas guías

Clnical Practice Dissociated from Study Outcomes: Bad News for Our Patients?

solaci - 0
TCT 2021 | STOPDAPT-2 y MASTER-DAPT: la discusión continúa del ESC al TCT

TCT 2021 | STOPDAPT-2 and MASTER-DAPT: The Conversation Continues from ESC...

solaci - 0
TCT 2021 | STOPDAPT-2 y MASTER-DAPT: la discusión continúa del ESC al TCT

TCT 2021 | STOPDAPT-2 and MASTER-DAPT: The Conversation Continues from ESC...

solaci - 0

STOPDAPT-2 ACS: One-Month DAPT NOT Enough in acute patients

solaci - 0

XIENCE SHORT DAPT | Ideal DAPT Period for Patients at High...

solaci - 0
SOLACI-CACI 2021 Virtual

SOLACI-CACI 2021 | DAPT Session

solaci - 0
SCAI@SOLACI-CACI Session

SOLACI-CACI 2021 | SCAI Session

solaci - 0
1234...7Page 3 of 7

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Dr. Omar Tupayachi - 0
Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Noticias Institucionales

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

solaci - 0
Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

solaci - 0
The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad